04:19 PM EST, 12/13/2024 (MT Newswires) -- Pushkal Garg, Chief Medical Officer & Executive Vice President, Development & Medical Affairs, on December 12, 2024, sold 1,752 shares in Alnylam Pharmaceuticals ( ALNY ) for $439,760. Following the Form 4 filing with the SEC, Garg has control over a total of 16,386 shares of the company, with 15,705 shares held directly and 681 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000110/xslF345X05/edgardoc.xml